Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document provides an update on the preclinical and clinical development of Immunic's product candidates, including IMU-935, highlighting future plans and risks.
investor_presentation
62 Pages
Ventas, Inc.
Münchener Rückversicherungs-Gesellschaft Investor Presentation — August 2018
investor_presentationinvestor_presentation
52 Pages
Münchener Rückversicherungs-Gesellschaft
Philips Investor Presentation October 2023
investor_presentationinvestor_presentation
41 Pages
Koninklijke Philips N.V.
SolarWindow Technologies Q3 2021 Investor Presentation
investor_presentationinvestor_presentation
44 Pages
SolarWindow Technologies, Inc.
